The trademark application Kyverna was filed by Kyverna Therapeutics, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on September 30, 2020, and it was registered by office on January 8, 2021 without any oppositions.
The application was filed in English (German was selected as the second language).
Change of name and address of the trademark registration was recorded on April 5, 2021.
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceuticals
Pharmaceutical preparations
Therapeutic pharmaceuticals for the treatment of autoimmune disease
Pharmaceutical therapeutic agents for medical use
Cell therapy products for the treatment of autoimmune disease
Cells for medical use
Living cells for medical use
Therapeutic pharmaceuticals and cell therapy products in the nature of cells for medical or clinical use for the treatment of autoimmune disease
Cell therapy products, namely, genetically engineered immune cells for the treatment of autoimmune disease
Cell therapy products, namely, genetically engineered immune cells for medical or clinical use for the treatment of autoimmune disease
Antibodies
Antibody receptors
Antigens
Antigen receptors
Diagnostic agents, preparations and substances for medical purposes
Pharmaceutical products, namely, diagnostic reagents for medical purposes
Control reagents for medical laboratory purposes
Control reagents for clinical medical purposes.
The mark was filed in class 42 with following description of goods:
Scientific and technological services and research and design relating thereto
Industrial analysis and research services
Research, development, testing and evaluation of pharmaceuticals, pharmaceutical preparations and pharmaceutical therapeutic agents
Research, development, testing and evaluation of medical preparations, cells for medical use, antibodies, antibody receptors, antigens and antigen receptors
Medical research and development
Medical and scientific research and development in the field of diagnosis and treatment of autoimmune disease
Research, development, testing and evaluation of diagnostic agents, preparations and substances for medical purposes
Information, advice and consultancy regarding the aforementioned services.
The mark was filed in class 44 with following description of goods:
Medical services
Medical information services
Medical testing services
Medical diagnostic testing services
Medical treatment services
Medical services for the diagnosis and treatment of autoimmune disease
Medical services, namely, cell based therapies
Information, advice and consultancy regarding the aforementioned services.